期刊文献+

73例急性早幼粒细胞性白血病患者临床特点和预后分析 被引量:5

暂未订购
导出
摘要 目的探讨急性早幼粒细胞性白血病(acute promyelocytic leukemia,APL)患者的临床特点及生存情况。方法回顾性分析73例APL患者的临床特点和生存情况。结果初诊患者平均年龄为33.2岁,男女患者性别比为1.22∶1。其主要临床表现包括出血(95.9%)、贫血(94.5%)、发热(58.9%)、肝肿大(57.5%)和脾肿大(38.4%)等。随访时间为5.1~114.9个月,平均随访时间为(36.5±3.6)个月。患者完全缓解率(CR)为76.7%。完全缓解率高低与初诊时外周血幼稚细胞比例相关。Kaplan-Meier曲线生存率分析表明,患者预期1、3、5年无事件生存率(event-free survival,EFS)分别为69.9%、62.5%、54.8%。结论出血是APL患者最常见和显著的临床表现。全反式维甲酸联合其他药物的化疗方案治疗APL疗效满意,可望进一步通过减少早期病死率来提高疗效。根据患者外周血幼稚细胞比例等临床预后因素,采用个体化治疗方案,对于提高生存率具有重要指导意义。
出处 《广东医学》 CAS CSCD 北大核心 2011年第5期635-637,共3页 Guangdong Medical Journal
  • 相关文献

参考文献14

  • 1LO COCO F, AMMATUNA E, MONTESINOS P, et al. Acute promyelocytic leukemia: recent advances in diagnosis and manage- ment[J]. Semin Oncol, 2008, 35(4): 401 -409.
  • 2JACOMO R H, MELO R A, SOUTO F R, et al. Clinical features and outcomes of 134 Brazilians with acute promyelocytie leukemia who received ATRA and anthracyclines [ J ]. Haematologica, 2007, 92(10) : 1431 - 1432.
  • 3SANZ M A, LO COCO F, MARTIN G, et al. Definition of relapse risk and role of nonanthracychne drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA cooperative groups[J]. Blood, 2000, 96(4): 1247- 1253.
  • 4SEREFHANOGLU S, BUYUKASIK Y, GOKER H, et al. Clini- cal features and outcomes of 49 Turkish patients with acute promy- elocytic leukemia who received ATRA and anthracyclines (PET- HEMA protocol) therapy[ J]. Leuk Res, 2010, 34(12) : e317 - e319.
  • 5SHARMA J B, GUPTA N, VIMALA N, et al. Acute promyelocyt- ic leukemia: an unusual cause of fatal secondary postpartum hemorrhage [ J ]. Arch Gynecol Obstet, 2006, 273 (5) : 310 - 311.
  • 6ALYMARA V, TZOUVARA E, VARTHOLOMATOS G, et al. single - center, retrospective study of management and outcome of 45 elderly AML patients, diagnosed in 2001 [ J]. J Exp Clin Cancer Res, 2004, 23 (3) : 447 - 454.
  • 7MONTESINOS P, BERGUA J M, VELLENGA E, et al. Differen- tiation syndrome in patients with acute promyelocytic leukemia treated with all - trans retinoic acid and anthracycline chemotherapy: characteristics, outcome, and prognostic factors [ J ]. Blood, 2009, 113(4) : 775 -783.
  • 8马向娟,任汉云,岑溪南,邱志祥,王文生,欧晋平,王颖,许蔚林,李渊,王茫桔,王莉红,董玉君,尹玥,梁赜隐.化疗、全反式维甲酸联合砷剂序贯治疗成人急性早幼粒细胞白血病疗效分析[J].中华血液学杂志,2010,31(5):328-332. 被引量:31
  • 9ADdS L, GUERCI A, RAFFOUX E, et al. Very long - term outcome of acute promyelocytic leukemia after treatment with all - trans retinoic acid and chemotherapy: the European APL Group experience[J]. Blood, 2010, 1t5(9): 1690-1696.
  • 10OHNO R, ASOU N, Japan Adult Leukemia Study Group. The recent JALSG study for newly diagnosed patients with acute promyelocytic leukemia (APL) [ J]. Ann Hematol, 2004, 83 ( Suppl 1 ) : S77 - S78.

二级参考文献9

  • 1Fenaux P,Castaigne S,Dombret H,et al.All-trans retinoic acid followed by intensive chemotherapy gives a high complete remission rate and may prolong remissions in newly diagnosed acute promyelocytic leukemia:a pilot study on 26 cases.Blood,1992,80:2176-2181.
  • 2Muindi J,Frankel SR,Miller WH,et al.Continuous treatment with all-trans tetinoic acid causes a progressive reduction in plasma drug concentration:implications for relapse and retinoid "resistance" in patients with acute promyelocytic leukemia.Blood,1992,79:299-303.
  • 3Sanz MA,Lo CocoF,Martin G,et al.Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia:a joint study of the PETHEMA and GIMEMA cooperative groups.Blood,2000,96:1247-1253.
  • 4Shen ZX,Chen GQ,Wi JH,et al.Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL),Ⅱ.clinical efficacy and pharmacokinetics in relapesed patients.Blood,1997,89:3354-3360.
  • 5Mathews V,George B,Lakshmi KM,et al.Single-agent arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia:durable remissions with minimal toxicity.Blood,2006,107:2627-2632.
  • 6Gianni M,Koken M,Chelbi-Alix MK,et al.Combined arsenic and retinoic acid treatment enhances differentiation and apoptosis in arsenic-resistant NB4 cells.Blood,1998,91:4300-4310.
  • 7Li X,Sun WJ,Li ZJ,et al.A survival study and prognostic factors analysis on acute promyelocytic leukemia at a single center.Leuk Res,2007,31:765-771.
  • 8Sanz MA,Tallman MS,Lo-Coco F,et al.Tricks ofthe trade for the appropriate management of newly diagnosed acute promyelocytic leukemia.Blood,2005,105:3019-3025.
  • 9全反式维甲酸治疗544例急性早幼粒细胞白血病的临床研究[J].中华血液学杂志,1992,13(3):135-137. 被引量:94

共引文献30

同被引文献43

引证文献5

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部